Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | Alvocidib | 0.1 | 0.6771 | -0.00643 |
| HCC1395 | Alvocidib | 0.1 | 0.6860 | 0.01323 |
| HCC1395 | Alvocidib | 0.316227766017 | 0.0265 | 0.01840 |
| HCC1395 | Alvocidib | 0.316227766017 | 0.0320 | 0.06861 |
| T47D | Alvocidib | 0.0001 | 0.9963 | -0.00690 |
| MCF7 | Alvocidib | 0.000316228 | 0.8366 | 0.00209 |
| HCC1143 | Alvocidib | 0.0316227766017 | 0.9465 | 0.00296 |
| HCC1419 | Alvocidib | 0.0001 | 1.1161 | -0.00419 |
| T47D | Alvocidib | 0.003162278 | 1.0160 | -0.00208 |
| HCC1419 | Alvocidib | 0.000316227766017 | 1.2391 | -0.00328 |
| HCC1419 | Alvocidib | 0.000316227766017 | 0.9570 | -0.00053 |
| HCC1419 | Alvocidib | 0.001 | 0.9401 | -0.00975 |
| HCC1143 | Alvocidib | 0.000316227766017 | 1.0520 | 0.00267 |
| HCC1419 | Alvocidib | 0.00316227766017 | 1.0282 | -0.00825 |
| HCC1419 | Alvocidib | 0.01 | 0.9843 | -0.01083 |
| HCC1419 | Alvocidib | 0.01 | 0.9485 | 0.01266 |
| HCC1143 | Alvocidib | 0.0001 | 1.0177 | -0.00582 |
| HCC1143 | Alvocidib | 0.000316227766017 | 0.9674 | 0.00123 |
| HCC1143 | Alvocidib | 0.0001 | 1.0051 | -0.01287 |
| HCC1143 | Alvocidib | 0.0001 | 1.0322 | -0.00311 |
| T47D | Alvocidib | 0.0001 | 0.4725 | 0.01152 |
| HCC1143 | Alvocidib | 0.001 | 0.9014 | -0.00609 |
| T47D | Alvocidib | 0.0001 | 1.0436 | 0.00888 |
| MDA-MB-157 | Alvocidib | 0.000316227766017 | 0.9639 | 0.03632 |
| MDA-MB-157 | Alvocidib | 0.000316227766017 | 0.7703 | -0.02871 |